PD-L2 is a second ligand for PD-1 and inhibits T cell activation

Keywords

T-cell receptorCD28T cellCell biologyCytokinePD-L1ReceptorChemistryBiologyCancer researchMolecular biologyImmune systemImmunologyImmunotherapyBiochemistry

Affiliated Institutions

Related Publications

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Sanjeev Mariathasan , Shannon J. Turley , Dorothee Nickles +39 more

2018 Nature 5078 citations

Cancer immunotherapy using checkpoint blockade

Antoni Ribas , Jedd D. Wolchok

The release of negative regulators of immune activation (immune checkpoints) that limit antitumor responses has resulted in unprecedented rates of long-lasting tumor responses i...

2018 Science 6236 citations

The B7–CD28 superfamily

Arlene H. Sharpe , Gordon J. Freeman

2002 Nature reviews. Immunology 1660 citations

The biologic importance of tumor‐infiltrating lymphocytes

F. Stephen Hodi , Glenn Dranoff

Detailed pathologic analysis has delineated a close association between intratumoral CD 8 + cytotoxic T cells and favorable clinical outcomes in diverse cancers. Conversely, the...

2010 Journal of Cutaneous Pathology 55 citations

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

Peng Jiang , Shengqing Gu , Deng Pan +12 more

2018 Nature Medicine 5230 citations

Publication Info

Year: 2001
Type: article
Volume: 2
Issue: 3
Pages: 261-268
Citations: 2901
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

2901

OpenAlex

Cite This

APA Style

                            
                                
                                    Yvette Latchman, 
                                
                                    Clive R. Wood, 
                                
                                    Tatyana Chernova
                                
                                et al.
                            
                            (2001). 
                            PD-L2 is a second ligand for PD-1 and inhibits T cell activation. 
                            Nature Immunology
                            , 2
                            (3)
                            , 261-268.
                            https://doi.org/10.1038/85330
                        

Identifiers

DOI: 10.1038/85330